Ligand validation:4R1M

AMP: ADENOSINE MONOPHOSPHATE

AMP is a Ligand Of Interest in 4R1M designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4R1M_AMP_B_502	70%	61%	0.146	0.964	0.64	0.86	-	2	0	0	100%	1
4R1M_AMP_D_502	65%	58%	0.132	0.935	0.66	0.95	-	2	0	0	100%	1
4R1M_AMP_A_502	26%	59%	0.212	0.854	0.7	0.87	-	1	0	0	100%	1
4RVN_AMP_D_502	84%	65%	0.094	0.957	0.57	0.76	-	1	2	0	100%	1
4R1L_AMP_A_503	80%	60%	0.134	0.983	0.69	0.82	-	1	0	0	100%	0.5
8YNQ_AMP_D_504	100%	43%	0.041	0.99	0.96	1.26	1	2	11	0	100%	1
3G89_AMP_B_304	100%	32%	0.038	0.986	1.05	1.63	1	4	6	0	100%	1
3LOQ_AMP_A_271	100%	45%	0.039	0.987	0.82	1.3	-	2	2	0	100%	1
7SNB_AMP_A_303	100%	55%	0.045	0.993	0.75	0.98	-	1	0	0	100%	0.78
3FWZ_AMP_B_601	100%	32%	0.037	0.984	1.15	1.55	2	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.